BC
Birchview Capital Portfolio holdings
AUM
$101M
This Quarter Return
+9.5%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$155M
AUM Growth
+$7.79M
(+5.3%)
Cap. Flow
-$2.87M
Cap. Flow
% of AUM
-1.85%
Top 10 Holdings %
Top 10 Hldgs %
83.08%
Holding
58
New
5
Increased
5
Reduced
13
Closed
4
Top Buys
| 1 |
AMRN
Amarin Corp
AMRN
|
$651K |
| 2 |
DOVA
Dova Pharmaceuticals, Inc. Common Stock
DOVA
|
$629K |
| 3 |
CMTA
Clementia Pharmaceuticals Inc.
CMTA
|
$602K |
| 4 |
Arvinas
ARVN
|
$506K |
| 5 |
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
|
$388K |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$1.43M |
| 2 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
$925K |
| 3 |
CFRX
ContraFect Corporation
CFRX
|
$577K |
| 4 |
Veracyte
VCYT
|
$478K |
| 5 |
Ovintiv
OVV
|
$446K |
Sector Composition
| 1 | Healthcare | 96.81% |
| 2 | Energy | 2.32% |
| 3 | Consumer Staples | 0.25% |
| 4 | Industrials | 0.16% |
| 5 | Consumer Discretionary | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Cytokinetics
CYTK
$6.13B
| $99K | 0.06% |
10,000
| – | – |
|
52
TG Therapeutics
TGTX
$5.02B
| $84K | 0.05% |
15,000
| – | – |
|
|
BIOL
53
DELISTED
Biolase, Inc.
BIOL
| $83K | 0.05% |
16
-38
| -70% | -$197K |
|
54
Workhorse Group
WKHS
$19.7M
| $27K | 0.02% |
100
| – | – |
|
|
CLVS
55
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – |
-5,000
| Closed | -$227K |
|
|
CELGZ
56
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
| – | – |
-241,877
| Closed | -$98K |
|
|
APTX
57
DELISTED
Aptinyx Inc. Common Stock
APTX
| – | – |
-10,000
| Closed | -$242K |
|